openPR Logo
Press release

Genomics in Cancer Care Market: Underpinning Growth Through Robust CAGR of 17.8% with Increasing Prevalence of Cancer

01-21-2025 09:36 AM CET | IT, New Media & Software

Press release from: The Business Research Company

Genomics in Cancer Care Market

Genomics in Cancer Care Market

Genomics in Cancer Care shows rapid growth driven by advancements in personalized medicine and reduced cost of genomic sequencing.

What Is The Projected Market Size Of The Genomics In Cancer Care Market And Its Growth Rate?
The market size of Genomics in Cancer Care is witnessing a substantial rise globally, attributed to continual advancements and initial market penetration.
•2024 Market Size: $17.6 billion
•2025 Market Size: $20.73 billion (17.8% CAGR)
•2029 Market Size: $38.57 billion (16.8% CAGR)

The growth is primarily driven by developments in companion diagnostics, data standardization, increasing prevalence of cancer, advancements in data analytics, improving healthcare infrastructure, and more.

What Is Driving The Growth In The Genomics In Cancer Care Market?
The surge in demand for cancer diagnostics is playing a pivotal role in driving the Genomics in Cancer Care market growth. Cancer diagnostics implicates identifying the exact type, location, extent, and stage of the tumor through accurate tests and procedures, thereby confirming the presence of the disease. Extending the boundaries of genomics in cancer care assists in identifying an appropriate treatment plan for cancer patients, keeping their genetic backgrounds in consideration. For instance, according to The Cancer Research UK, a UK-based cancer research organization, a significant rise in new cancer cases is expected from approximately 420,000 cases during 2023-2025 to about 506,000 cases by 2038-2040. Therefore, the growing demand for cancer diagnostics is anticipated to propel the genomics in cancer care market.

Request A Free Sample Copy:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8159&type=smp

Who Are the Key Players Driving Genomics In Cancer Care Market Growth?
The key companies operating in the Genomics in Cancer Care market are:
•Illumina Inc.
•Thermo Fisher Scientific Inc.
•Agilent Technologies Inc.
•PerkinElmer Inc.
•QIAGEN N.V.
•Bio-Rad Laboratories Inc.
•Danaher Corporation
•Pacific Biosciences of California Inc.
•Roche Holding AG
•Quest Diagnostics Incorporated, and others.

What Are The Key Trends In The Genomics In Cancer Care Market?
The key market trends include:
•Technological advancements
•Emergence of personalized medicine
•Reduced costs of genomic sequencing
•Regulatory support and guidelines
•Growing patient awareness and demand

What Are The Segments Of The Genomics In Cancer Care Market?
The Genomics in Cancer Care market is segmented into:
1) By Product Type: Instruments, Consumables, Services
2) By Technology: PCR (?Polymerase Chain Reaction), MicroArrays, Genome Sequencing, Other Technologies
3) By Application: Diagnostics, Personalized Medicine, Drug Discovery And Development, Research
4) By End-User: Hospitals, Government Institutes, Research Facilities

Which Region Leads The Genomics In Cancer Care Market?
North America was the leading region in the Genomics in Cancer Care market as of 2024. However, Asia-Pacific is expected to be the fastest-growing region in the forecast period, with substantial advancements in healthcare infrastructure, increased public awareness, and emerging economies as its growth pillars. The regions covered in the report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Pre-book the report for swift delivery:
https://www.thebusinessresearchcompany.com/report/genomics-in-cancer-care-global-market-report

What Is Covered In The Genomics In Cancer Care Market Global Market Report?
- Market Size Analysis: Analyze the Genomics In Cancer Care Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Genomics In Cancer Care Market for effective categorization.
- Key Player Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Genomics In Cancer Care Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Genomics In Cancer Care Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Request Customization for This Report: https://www.thebusinessresearchcompany.com/Customise?id=8159&type=smp

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: mailto:info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Learn More About The Business Research Company

The Business Research Company ( https://www.thebusinessresearchcompany.com ) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Genomics in Cancer Care Market: Underpinning Growth Through Robust CAGR of 17.8% with Increasing Prevalence of Cancer here

News-ID: 3824567 • Views:

More Releases from The Business Research Company

Segment Evaluation and Major Growth Areas in the Personalized Testing and Supplements Market
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future. Market Valuation and Expansion Forecast for Personalized Testing
Top Players and Market Competition in the Skin Microbiome Industry
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry. Projected Expansion in the Skin
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market Landscape
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory. Steady Growth Expected in Upadacitinib Market Size Through 2029 The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Market
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field. Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics

All 5 Releases


More Releases for Cancer

Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose. Increase in incidence of target diseases like cancer is key driving factor which is expected to boost
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business. Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports. Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For